Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Pre-Transplant Serum Beta-2 Microglobulin Level Is a Potential Novel Prognostic Marker for Overall Survival after Allogeneic Hematopoietic Stem Cell Transplantation

Naonori Harada, Takahiko Nakane, MD PhD, Mika Nakamae, MD PhD, Hiroshi Okamura, Satoru Nanno, MD PhD, Mitsutaka Nishimoto, MD PhD, Yasunobu Takeoka, MD PhD, Asao Hirose, MD PhD, Yasuhiro Nakashima, MD PhD, Hideo Koh, MD PhD, Masayuki Hino, MD PhD, Hirohisa Nakamae, MD PhD

Blood (2018) 132 (Supplement 1): 4664.

https://doi.org/10.1182/blood-2018-99-111679

Published: 2018

Journal Articles

The Proportional Association between WT1 mRNA Level in Peripheral Blood before Allogeneic Hematopoietic Cell Transplantation and Risk of Mortality in Acute Myeloid Leukemia Not in Remission

Kentaro Ido, MD, Mika Nakamae, MDPhD, Hideo Koh, MDPhD, Hiroshi Okamura, Satoru Nanno, MD PhD, Mitsutaka Nishimoto, MDPhD, Yoshinori Hashimoto, MD, Yasunobu Takeoka, MDPhD, Asao Hirose, MDPhD, Yasuhiro Nakashima, MDPhD, Takahiko Nakane, MD PhD, Masayuki Hino, MDPhD, Hirohisa Nakamae, MDPhD

Blood (2018) 132 (Supplement 1): 4665.

https://doi.org/10.1182/blood-2018-99-111834

Published: 2018

Journal Articles

Pre-Transplant Transferrin Saturation Levels As a Predictive Marker for Invasive Fungal Disease Following Allogeneic Hematopoietic Stem Cell Transplantation

Satoru Nanno, MDPhD, Hideo Koh, MDPhD, Mitsutaka Nishimoto, MDPhD, Takahiko Nakane, MDPhD, Yasuhiro Nakashima, MDPhD, Yasunobu Takeoka, MDPhD, Mika Nakamae, MDPhD, Asao Hirose, MDPhD, Masayuki Hino, MDPhD, Hirohisa Nakamae, MDPhD

Blood (2017) 130 (Supplement 1): 1965.

https://doi.org/10.1182/blood.V130.Suppl_1.1965.1965

Published: 2017

Journal Articles

Prophylactic Use of a Combination of an Anticoagulant and Ursodeoxycholic Acid for Sinusoidal Obstruction Syndrome after Allogeneic Myeloablative Hematopoietic Stem Cell Transplantation

Hiroshi Okamura, MD, Mitsutaka Nishimoto, MD,PhD, Takahiko Nakane, MD, PhD, Hideo Koh, MD,PhD, Yasuhiro Nakashima, MD, PhD, Yasunobu Takeoka, MD, PhD, Mika Nakamae, MD,PhD, Asao Hirose, MD, PhD, Masayuki Hino, MD, PhD, Hirohisa Nakamae, MD PhD

Blood (2016) 128 (22): 5755.

https://doi.org/10.1182/blood.V128.22.5755.5755

Published: 2016

Journal Articles

Combination of Frailty Status and Comorbidity Score Improves the Prediction of Survival in Patients with Myelodysplastic Syndrome Due to Good Predictive Capability for Infection-Related Mortality

Kazuki Sakatoku, MD, Yasunobu Takeoka, MD, PhD, Taku Araki, MD, Ryosuke Yamamura, MD, PhD, Takahiko Nakane, MD, PhD, Hirohisa Nakamae, MD PhD, Masayuki Hino, MD, PhD, Kensuke Ohta, MD, PhD

Blood (2016) 128 (22): 1995.

https://doi.org/10.1182/blood.V128.22.1995.1995

Published: 2016

Journal Articles

A Detailed Analysis of Myelodysplastic Syndrome Complicated By Autoimmune or Inflammatory Disorders: A Possible Efficacy of Low-Dose Lenalidomide

Yasunobu Takeoka, Akiko Miura, Koji Nakamura, Junko Nakamura, Ryosuke Yamamura, MD PhD, Taku Araki, Hirohisa Nakamae, Masayuki Hino, Prof., Kensuke Ohta, MD PhD

Blood (2014) 124 (21): 3256.

https://doi.org/10.1182/blood.V124.21.3256.3256

Published: 2014

Journal Articles

The Diagnostic and Prognostic Utility of 18F-FDG PET/CT in Transplant Ineligible Multiple Myeloma Patients Receiving Novel Agents

Yasunobu Takeoka, Ryosuke Yamamura, MD, PhD, Taku Araki, Akiko Inaba, Yotaro Fujitani, Genju Koh, Hirotaka Seura, Terue Okamura, Kensuke Ohta, MD, PhD

Blood (2013) 122 (21): 1883.

https://doi.org/10.1182/blood.V122.21.1883.1883

Published: 2013

Journal Articles

The Impact of Relative Dose Intensity of Rituximab-CHOP on Survival in Diffuse Large B-Cell Lymphoma Patients

Yoshiki Terada, MD, PhD, Hirohisa Nakamae, MD, PhD, Ran Moriguchi, MD, Hiroshi Kanashima, MD, PhD, Erina Sakamoto, MD, PhD, Dai Momose, MD, Mizuki Aimoto, MD, Shuichirou Okamoto, MD, Eri Wada, MD, Hideo Koh, MD, Takahiko Nakane, MD, Yasunobu Takeoka, MD, Ki- Ryang Koh, MD, PhD, Takahisa Yamane, MD, PhD, Yoshitaka Nakao, MD, PhD, Kensuke Ohta, MD, PhD, Atsuko Mugitani, MD, PhD, Hirofumi Teshima, MD, PhD, Masayuki Hino, MD, PhD

Blood (2008) 112 (11): 4931.

https://doi.org/10.1182/blood.V112.11.4931.4931

Published: 2008

Journal Articles

Possible Involvement of γδ-T Cells in the Development of Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.

Ki-Ryang Koh, MD, PhD, Hirohisa Nakamae, M.D., Ph.D., Kensuke Ohta, M.D., Ph.D., Hongzhang Li, M.D., Hideo Koh, M.D., Takahiko Nakane, M.D., Yasunobu Takeoka, M.D., Asao Hirose, M.D., Ph.D., Kiyoyuki Hagihara, M.D., Ph.D., Erina Sakamoto, M.D., Ph.D., Mika Nakamae, M.D., Ph.D., Yoshiki Terada, M.D., Ph.D., Takahisa Yamane, M.D., Ph.D., Masayuki Hino, M.D., Ph.D.

Blood (2007) 110 (11): 1971.

https://doi.org/10.1182/blood.V110.11.1971.1971

Published: 2007

Journal Articles

The Impact of Relative Dose Intensity (RDI) of CHOP on Outcome of Diffuse Large B-Cell Lymphoma: Results of a Single Center Study.

Yoshiki Terada, MD, PhD, Hirohisa Nakamae, M.D., Ph.D., Takahiko Nakane, M.D., Hideo Koh, M.D., Yasunobu Takeoka, M.D., Ran Moriguchi, M.D., Mizuki Aimoto, M.D., Yuki Akazawa, M.D., Eri Wada, M.D., Hiroshi Kanashima, M.D., Ph.D., Erina Sakamoto, M.D., Ph.D., Ki-Ryang Koh, M.D., Ph.D., Takahisa Yamane, M.D., Ph.D., Kensuke Ohta, M.D., Ph.D., Yoshitaka Nakao, M.D., Ph.D., Hirofumi Teshima, M.D., Ph.D., Masayuki Hino, M.D., Ph.D.

Blood (2007) 110 (11): 4456.

https://doi.org/10.1182/blood.V110.11.4456.4456

Published: 2007

Journal Articles

Decreased Serum Levels of Surfactant Protein D (SP-D) Prior Transplant Is Associated with the Development of Bronchiolitis Obliterans (BO) and Idiopathic Pneumonia Syndrome (IPS) Following Allogeneic Hematopoietic Stem Cell Transplantation.

Takahiko Nakane, MD, Hirohisa Nakamae, M.D.,Ph.D., Hiroshi Kamoi, M.D.,Ph.D., Hideo Koh, M.D., Yasunobu Takeoka, M.D., Erina Sakamoto, M.D.,Ph.D., Hiroshi Kanashima, M.D.,Ph.D., Hiroyoshi Ichihara, M.D., Mika Nakamae, M.D.,Ph.D., Ki-Ryang Koh, M.D.,Ph.D., Takahisa Yamane, M.D.,Ph.D., Masayuki Hino, M.D.,Ph.D.

Blood (2006) 108 (11): 2915.

https://doi.org/10.1182/blood.V108.11.2915.2915

Published: 2006

Journal Articles

Preferential Th2 Polarization at the Onset of Thrombotic Microangiopathy (TMA): Immunological Comparison of TMA Versus Acute GVHD in Terms of Peripheral T Cell Subsets, Dendritic Cell Subsets and Cytokine Profiles.

Ki-Ryang Koh, MD, PhD, Hirohisa Nakamae, M.D., Ph. D., Kensuke Ohta, M.D., Ph. D., Hideo Koh, M.D., Takahiko Nakane, M.D., Mika Nakamae, M.D., Ph. D., Hiroshi Kanashima, M.D., Ph. D., Kiyoyuki Hagihara, M.D., Ph. D., Erina Sakamoto, M.D., Ph. D., Yoshiki Terada, M.D., Ph. D., Yasunobu Takeoka, M.D., Asao Hirose, M.D., Ph. D., Takahisa Yamane, M.D., Ph. D., Masayuki Hino, M.D., Ph.D

Blood (2006) 108 (11): 2885.

https://doi.org/10.1182/blood.V108.11.2885.2885

Published: 2006

Journal Articles

Risk Factor Analysis for Thrombotic Microangiopathy after Reduced Intensity or Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation.

Hirohisa Nakamae, MD, PhD, Takahisa Yamane, MD, PhD, Hagihara Kiyoyuki, MD., PhD., Yasunobu Takeoka, MD., Erina Sakamoto, MD., PhD., Takahiko Nakane, MD., Mika Nakamae, MD., PhD., Ki-Ryang Koh, MD., PhD., Kensuke Ohta, MD., PhD., Masayuki Hino, MD., PhD.

Blood (2005) 106 (11): 1775.

https://doi.org/10.1182/blood.V106.11.1775.1775

Published: 2005

Journal Articles

Significant and Morbid Changes in Heart Rate Variability Precedes and Complicates Symptomatic Hypotension in Peripheral Blood Stem Cell Apheresis.

Hirohisa Nakamae, M.D., Ph.D., Yoshiki Terada, M.D., Ph.D., Mika Akahori, M.D., Takahiko Nakane, M.D., Kiyoyuki Hagihara, M.D., Yasunobu Takeoka, M.D., Taro Hasegawa, M.D., Ph.D., Kensuke Ohta, M.D., Ph.D., Takahisa Yamane, M.D., Ph.D., Masayuki Hino, M.D., Ph.D.

Blood (2004) 104 (11): 4996.

https://doi.org/10.1182/blood.V104.11.4996.4996

Published: 2004

NARROW

Pre-Transplant Serum Beta-2 Microglobulin Level Is a Potential Novel Prognostic Marker for Overall Survival after Allogeneic Hematopoietic Stem Cell Transplantation

The Proportional Association between WT1 mRNA Level in Peripheral Blood before Allogeneic Hematopoietic Cell Transplantation and Risk of Mortality in Acute Myeloid Leukemia Not in Remission

Pre-Transplant Transferrin Saturation Levels As a Predictive Marker for Invasive Fungal Disease Following Allogeneic Hematopoietic Stem Cell Transplantation

Prophylactic Use of a Combination of an Anticoagulant and Ursodeoxycholic Acid for Sinusoidal Obstruction Syndrome after Allogeneic Myeloablative Hematopoietic Stem Cell Transplantation

Combination of Frailty Status and Comorbidity Score Improves the Prediction of Survival in Patients with Myelodysplastic Syndrome Due to Good Predictive Capability for Infection-Related Mortality

A Detailed Analysis of Myelodysplastic Syndrome Complicated By Autoimmune or Inflammatory Disorders: A Possible Efficacy of Low-Dose Lenalidomide

The Diagnostic and Prognostic Utility of 18F-FDG PET/CT in Transplant Ineligible Multiple Myeloma Patients Receiving Novel Agents

The Impact of Relative Dose Intensity of Rituximab-CHOP on Survival in Diffuse Large B-Cell Lymphoma Patients

Possible Involvement of γδ-T Cells in the Development of Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.

The Impact of Relative Dose Intensity (RDI) of CHOP on Outcome of Diffuse Large B-Cell Lymphoma: Results of a Single Center Study.

Decreased Serum Levels of Surfactant Protein D (SP-D) Prior Transplant Is Associated with the Development of Bronchiolitis Obliterans (BO) and Idiopathic Pneumonia Syndrome (IPS) Following Allogeneic Hematopoietic Stem Cell Transplantation.

Preferential Th2 Polarization at the Onset of Thrombotic Microangiopathy (TMA): Immunological Comparison of TMA Versus Acute GVHD in Terms of Peripheral T Cell Subsets, Dendritic Cell Subsets and Cytokine Profiles.

Risk Factor Analysis for Thrombotic Microangiopathy after Reduced Intensity or Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation.

Significant and Morbid Changes in Heart Rate Variability Precedes and Complicates Symptomatic Hypotension in Peripheral Blood Stem Cell Apheresis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only